We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Impairment in Glucose Homeostasis Among Obese Adolescents in High Risk Diabetes Prone Population - Jisr Az-Zarqa Village

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01535105
Recruitment Status : Unknown
Verified February 2012 by Meir Medical Center.
Recruitment status was:  Recruiting
First Posted : February 17, 2012
Last Update Posted : March 14, 2013
Information provided by (Responsible Party):
Meir Medical Center

Brief Summary:

Obesity is increasing all over the world in adults, adolescents and children,and is followed by morbidity, including the metabolic syndrome.

Hypothesis: Among obese adolescents there is a subgroup with impaired glucose homeostasis

The aim of the study is to identify adolescents with impaired glucose metabolism, 12-18 years, among high risk diabetes prone population, for diagnosis and treatment.

Condition or disease
Glucose Metabolism Disorders

Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Study Start Date : August 2012
Estimated Primary Completion Date : April 2013
Estimated Study Completion Date : April 2017

Obese Adolescents

Primary Outcome Measures :
  1. Frequency of Impaired Glucose Homeostasis among obese adolescents in high risk diabetes prone population [ Time Frame: one year ]

Secondary Outcome Measures :
  1. Description of the metabolic profile in obese adolescents [ Time Frame: One year ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   12 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects of the study will be selected from a primary care clinic

Inclusion Criteria:

  • Clinical diagnosis of obesity

Exclusion Criteria:

  • History of disease or drug therapy affecting glucose metabolism

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01535105

Contact: Nehama Zuckerman-Levin, MD 972-524354143 zuckerln@netvision.net.il

Clalit Health Services Clinic Recruiting
Jisr az-Zarqa village, Israel
Contact: Nehama Zuckerman-Levin, MD    072524354143    zuckerln@netvision.net.il   
Principal Investigator: Nehama Zuckerman-Levin, MD         
Sponsors and Collaborators
Meir Medical Center
Principal Investigator: Nehama Zuckerman-Levin, MD Clalit Health Services

Responsible Party: Meir Medical Center
ClinicalTrials.gov Identifier: NCT01535105     History of Changes
Other Study ID Numbers: Gl homeostasis and obesity
First Posted: February 17, 2012    Key Record Dates
Last Update Posted: March 14, 2013
Last Verified: February 2012

Additional relevant MeSH terms:
Metabolic Diseases
Glucose Metabolism Disorders